3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
23
Breast Neoplasms
12
Prostatic Neoplasms
11
Triple Negative Breast Neoplasms
7
Fallopian Tube Neoplasms
7
Stomach Neoplasms
5
Neoplasm Metastasis
5
Sarcoma
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Metastatic Castration-resistant Prostate Cancer
4
Fanconi Anemia, Complementation Group D1
4
Small Cell Lung Carcinoma
3
Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Wilms Tumor
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Endometrial Neoplasms
2
Interventions
Cisplatin
27
Cetuximab
17
Radiotherapy
14
Carboplatin
14
pembrolizumab
11
Paclitaxel
11
Drug Therapy
8
Radiotherapy, Intensity-Modulated
7
Nivolumab
7
Fluorouracil
7
Erlotinib Hydrochloride
7
Radiation
6
Docetaxel
5
130-nm albumin-bound paclitaxel
5
Panitumumab
4
Chemoradiotherapy
3
Capecitabine
3
Bevacizumab
3
Albumin-Bound Paclitaxel
3
Afatinib
3
selinexor
2
figitumumab
2
Restraint, Physical
2
Radiosurgery
2
Methotrexate
2
Lapatinib
2
Everolimus
2
Esophagectomy
2
Cyclophosphamide
2
zalutumumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Squamous Cell
×
olaparib
×
Clear all
No trials found.